Worsening Conduction Delay in Hypertrophic Cardiomyopathy: What Drug Is Responsible?

Circulation. 2017 Aug 8;136(6):599-601. doi: 10.1161/CIRCULATIONAHA.117.029572.
No abstract available

Keywords: hypertrophic cardiomyopathy; propafenone.

Publication types

  • Case Reports

MeSH terms

  • Action Potentials
  • Anti-Arrhythmia Agents / adverse effects*
  • Atrioventricular Block / diagnosis
  • Atrioventricular Block / drug therapy*
  • Atrioventricular Block / etiology
  • Atrioventricular Block / physiopathology
  • Cardiomyopathy, Hypertrophic / complications*
  • Cardiomyopathy, Hypertrophic / diagnostic imaging
  • Cardiomyopathy, Hypertrophic / physiopathology
  • Electrocardiography*
  • Heart Conduction System / drug effects*
  • Heart Conduction System / physiopathology
  • Heart Rate / drug effects*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Propafenone / adverse effects*

Substances

  • Anti-Arrhythmia Agents
  • Propafenone